Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-10-06

FDA Approved: CALCIPOTRIENE — Original Application (Mayne Pharma)

View source ↗

Summary

FDA approved the original application for CALCIPOTRIENE from Mayne Pharma. It is a topical vitamin D analog indicated for plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcipotriene (calcipotriene)

Snippet

ORIG AP for CALCIPOTRIENE (CALCIPOTRIENE)